2019 International Congress Archives - Page 44 of 217

1:15pm-2:45pm: NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients

H. Alfaisal, F. Durif, S. Thobois, L. Defebvre, JP. Azulay, P. Couratier, P. Damier, D. Devos, S. Drapier, A. Doe Demaindreville, S. Frismand, C. Geny, C. Giordana, JL. Houeto, P. Krystkowiak, E. Magnin, D. Maltête, W. Meissner, C. Moreau, E. Moro, P. Remy, C. Thiriez, C. Tranchant, F. Viallet, M. Vidailhet, E. Dellapina, V. Chaigneau, C. Dongmo, F. Tubach, Y. de Rycke, O. Rascol, JC. Corvol (Paris, France)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Number of people with Parkinson’s dementia in New Zealand

T. Pitcher, D. Myall, J. Dalrymple-Alford, M. Macaskill, T. Anderson (Christchurch, New Zealand)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder

S. Eskildsen, A. Iranzo, M. Stokholm, K. Stær, K. østergaard, M. Eroles, M. Otto, K. Svendsen, A. Pla, D. Vilas, P. Borghammer, J. Santamaria, A. Møller, C. Gaig, D. Brooks, E. Tolosa, L. østergaard, N. Pavese (Aarhus N, Denmark)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Olfactory dysfunction in Parkinson’s disease

N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: One-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease

L. Barcelos, M. Tosin, M. Marinho, C. Silva, R. Saba, S. Silva, V. Borges, H. Ferraz (Sao Paulo, Brazil)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Online determination of the STN “sweet spot” based on beta-power measured with directional macro-contacts of the final DBS lead

M. Scherer, L. Milosevic, R. Guggenberger, A. Malekmohammadi, G. Naros, D. Weiss, A. Gharabaghi (Tübingen, Germany)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Opposing effects of levodopa on basal ganglia activity in Parkinson’s disease during motion and rest

R. Jech, S. Holiga, F. Růžička, H. Möller, J. Roth, M. Schroeter, E. Růžička, K. Mueller (Prague, Czech Republic)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Oromandibular Dystonia as an Initial Manifestation of Parkinson’s Disease: 2 Case Reports

F. Gao (San Francisco, CA, USA)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation for Parkinson’s Disease

J. Vesper, R. Jain, A. Wang, H. Scholtes, V. Study Group, G. Deuschl (Düsseldorf, Germany)

Non-Pharmacological Interventions · Les Muses Terrace, Level 3